Market News

Oak Street Slips On Wider-Than-Expected 4Q Loss; Street Sees 29% Upside

Shares of Oak Street Health fell 2.4% in Tuesday’s extended trading session after the operator of primary care centers for adults on Medicare reported a wider-than-expected loss for 4Q.

Oak Street (OSH) reported a net loss of $0.40 per share for the quarter, which was significantly wider than the Street’s estimates of a loss of $0.27 per share.

4Q revenues grew 43% year-over-year to $248.7 million and surpassed analysts’ expectations of $231.8 million. The company’s top-line performance reflected benefits from new center openings. In 2020, it opened 28 new care centers, including 12 centers in 4Q. (See Oak Street Health stock analysis on TipRanks)

For 1Q, Oak Street expects revenues of between $280 million and $285 million, which is well above the consensus estimate of $276.2 million. Additionally, the mid-point of the company’s full-year revenue guidance range of $1.275-$1.325 billion is in line with Street expectations.

On Feb. 17, Piper Sandler analyst Sean Wieland raised the stock’s price target to $69 (29.6% upside potential) from $59 and reiterated a Buy rating. In a note to investors, Wieland stated that the company is enhancing its footholds in the large and underpenetrated primary care space.

Overall, the rest of the Street has a bullish outlook on the stock with a Strong Buy consensus rating based on 6 Buys and 1 Hold. The average analyst price target of $68.60 implies upside potential of about 28.8% to current levels. Shares have gained about 6.5% since its listing on Aug. 6, 2020.

Related News:
Stitch Fix Plummets 22% In Pre-Market On Softer FY21 Revenue Outlook
Waitr Disappoints With 4Q Results; Shares Slide 15%
ContextLogic’s 1Q Revenue Outlook Exceeds Expectations After 4Q Beat; Shares Rise

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More